In this study, we report in vivo effects of dasatinib on the cellular composition of the hematopoietic and immune system in wild-type mice as well as in a tetracycline-inducible transgenic mouse model of BCR-ABL positive CML-like disease. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.